Author

Daly Ann

Professor of Pharmacogenetics, Newcastle University - Cited by 40,198 - Pharmacogenetics - Liver

Biography

Daly Ann is a Professor of Pharmacogenetics, Newcastle University. Verified email at ncl.ac.uk - Homepage · PharmacogeneticsLiver. ArticlesCited byPublic access have area of intrest include:-Pharmacogenetics; Pharmacogenomics; Regulatory agencies; Industry; Biomarkers
Title
Cited by
Year
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
D Pfister, NG Nunez, R Pinyol, O Govaere, M Pinter, M Szydlowska, ...Nature 592 (7854), 450-456, 2021202
563
2021
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
J Glasbey, A Ademuyiwa, A Adisa, E AlAmeer, AP Arnaud, F Ayasra, ...The Lancet Oncology 22 (11), 1507-1517, 2021202
156
2021
Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis
EA Selvaraj, FE Mózes, ANA Jayaswal, MH Zafarmand, Y Vali, JA Lee, ...Journal of hepatology 75 (4), 770-785, 2021202
120
2021
PharmVar GeneFocus: CYP2C19
MR Botton, M Whirl‐Carrillo, AL Del Tredici, K Sangkuhl, LH Cavallari, ...Clinical Pharmacology & Therapeutics 109 (2), 352-366, 2021202
69
2021
Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic
COVIDSurg Collaborative, JC Glasbey, D Nepogodiev, JFF Simoes, ...Colorectal Disease 23 (3), 732-749, 2021202
53
2021
Transcriptomics identify thrombospondin‐2 as a biomarker for NASH and advanced liver fibrosis
K Kozumi, T Kodama, H Murai, S Sakane, O Govaere, S Cockell, ...Hepatology 74 (5), 2452-2466, 2021202
48
2021
Genome‐wide association study and meta‐analysis on alcohol‐associated liver cirrhosis identifies genetic risk factors
TH Schwantes‐An, R Darlay, P Mathurin, S Masson, S Liangpunsakul, ...Hepatology 73 (5), 1920-1931, 2021202
46
2021
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease
O Govaere, SK Petersen, N Martinez-Lopez, J Wouters, M Van Haele, ...Journal of hepatology 76 (5), 1001-1012, 2022202
45
2022
A multiancestry genome-wide association study of unexplained chronic ALT elevation as a proxy for nonalcoholic fatty liver disease with histological and radiological validation
M Vujkovic, S Ramdas, KM Lorenz, X Guo, R Darlay, HJ Cordell, J He, ...Nature genetics 54 (6), 761-771, 2022202
36
2022
PharmVar GeneFocus: CYP2C9
K Sangkuhl, K Claudio‐Campos, LH Cavallari, JAG Agundez, ...Clinical Pharmacology & Therapeutics 110 (3), 662-676, 2021202
31
2021
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: the COVIDSurg mortality score
COVIDSurg CollaborativeThe British journal of surgery 108 (11), 1274, 2021202
31
2021
A genetic risk score and diabetes predict development of alcohol-related cirrhosis in drinkers
JB Whitfield, TH Schwantes-An, R Darlay, GP Aithal, SR Atkinson, ...Journal of hepatology 76 (2), 275-282, 2022202
25
2022
Genetic risk factors in drug‐induced liver injury due to isoniazid‐containing antituberculosis drug regimens
P Nicoletti, H Devarbhavi, A Goel, R Venkatesan, CE Eapen, JI Grove, ...Clinical Pharmacology & Therapeutics 109 (4), 1125-1135, 2021202
22
2021
Metabolic signatures across the full spectrum of non-alcoholic fatty liver disease
AJ McGlinchey, O Govaere, D Geng, V Ratziu, M Allison, J Bousier, ...Jhep Reports 4 (5), 100477, 2022202
21
2022
A PDCD1 Role in the Genetic Predisposition to NAFLD-HCC?
N Eldafashi, R Darlay, R Shukla, MV McCain, R Watson, YL Liu, ...Cancers 13 (6), 1412, 212
20
2021
Increased serum miR-193a-5p during non-alcoholic fatty liver disease progression: Diagnostic and mechanistic relevance
K Johnson, PJ Leary, O Govaere, MJ Barter, SH Charlton, SJ Cockell, ...JHEP Reports 4 (2), 100409, 2022202
17
2022
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia
WY Lin, SE Fordham, E Hungate, NJ Sunter, C Elstob, Y Xu, C Park, ...Nature Communications 12 (1), 6233, 2021202
15
2021
Peptide-based urinary monitoring of fibrotic nonalcoholic steatohepatitis by mass-barcoded activity-based sensors
SC Cazanave, AD Warren, M Pacula, F Touti, A Zagorska, N Gural, ...Science translational medicine 13 (616), eabe83, 2021202
9
2021
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study
E Akowuah, RA Benson, EJ Caruana, G Chetty, J Edwards, S Forlani, ...The Journal of thoracic and cardiovascular surgery 162 (2), e355-e372, 2021202
8
2021
Quantitative modeling of human liver reveals dysregulation of glycosphingolipid pathways in nonalcoholic fatty liver disease
P Sen, O Govaere, T Sinioja, A McGlinchey, D Geng, V Ratziu, ...Iscience 25 (9), 2022202
6
2022

Referred From: https://scholar.google.co.uk/citations?user=XWGXDxYAAAAJ&hl=en

Cited by
Citations 40198
h-index 101
i10-index 285
Recommended Journals
Open Access Journals